Forget AI Stocks: This Pharma Giant Is Using AI to Dominate Drug Discovery

And there's more than one way to monetize this technology.There's no denying modern-day artificial intelligence (AI) is doing some pretty cool stuff. But, to say it's been world-changing would be a bit of a stretch. We were all doing well enough without it just a few years ago.There is one particular area where AI appears poised to make a major impact for the better, though. That's drug development. And with some technological help from Nvidia (NVDA 2.21%), Eli Lilly (LLY +0.33%) is leading the charge. Eli ...